New preclinical findings provide validation for Silexion’s new systemic administration approach for SIL-204, demonstrating ...
SAN FRANCISCO -- Older patients' survival in metastatic pancreatic cancer had a significant association with baseline ...
Pancreatic cancer is one of the deadliest of all cancers. Only 12% of men diagnosed with pancreatic cancer are alive five ...
A new advanced form of treatment for one of the deadliest cancers worldwide, pancreatic cancer, may be on its way, research ...
The aging population and lifestyle-related factors contribute to a surge in pancreatic cancer cases. The aggressive nature of the disease and its high mortality rate demand innovative therapies.
Pancreatic cancer is one of the deadliest of all cancers. Only 12 per cent of men diagnosed with pancreatic cancer are alive five years after diagnosis; for women it is 14 per cent.
A phase 2a trial of IMM-1-104 plus chemotherapy demonstrated efficacy and tolerability in first- and second-line pancreatic ...
Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and ...